Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy

Published:2023-03 Issue:3 Volume:115 Page:622-628
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zhang Y. Helen^ORCID,Montagna Giacomo,Flynn Jessica,Gillespie Erin F.,Mamtani Anita,Zhang Zhigang,Braunstein Lior Z.,Powell Simon N.,Morrow Monica,Barrio Andrea,Khan Atif J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference18 articles.

1. The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): A review of 20,000 breast cancer patients in the National Cancer Data Base (NCDB);Fayanju;Ann Surg,2018

2. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: A landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial;Bonnefoi;Ann Oncol,2014

3. Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype;Symmans;J Clin Oncol,2017

4. Assessment of residual cancer burden and event-free survival in neoadjuvant treatment for high-risk breast cancer: An analysis of data from the I-SPY2 randomized clinical trial;Symmans;JAMA Oncol,2021

5. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: A multicentre pooled analysis of 5161 patients;Yau;Lancet Oncol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The analysis of transcriptomic signature of TNBC—searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity;Journal of Applied Genetics;2024-05-09

2. The analysis of transcriptomic signature of TNBC – searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity;2024-01-03